# Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer

> **NCT02389751** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Gastroesophageal Junction Adenocarcinoma
- Malignant Neoplasm of the Cervical Esophagus
- Malignant Neoplasm of the Thoracic Esophagus
- Stage IIA Esophageal Cancer AJCC v7
- Stage IIB Esophageal Cancer AJCC v7
- Stage IIIA Esophageal Cancer AJCC v7
- Stage IIIB Esophageal Cancer AJCC v7
- Stage IIIC Esophageal Cancer AJCC v7

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Ganetespib
- **DRUG:** Paclitaxel
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT02389751
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-10
- **Primary completion:** 2019-07-16
- **Final completion:** 2019-07-16
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2019-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02389751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02389751, "Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02389751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*